about the fund

Glympse Bio is transforming disease monitoring with a novel class of highly tunable and bioengineered activity sensors that query the body for disease status and report out clinically relevant insights rapidly and noninvasively.

Candesant is dedicated to developing novel solutions for excessive sweating and hyperhidrosis

Kallyope is developing an industry-leading platform to harness the gut-brain axis.

Gauss’ iPad-based Triton platform uses digital imaging and Artificial Intelligence to enable real time monitoring of surgical blood loss. The company’s platform is being used to address preventable maternal death and health complications in childbirth and surgery.

Dewpoint is translating new insights into biomolecular condensates and cellular function to uncover treatments for the toughest disease.

KenSci is a healthcare data science company that uses machine learning to provide operational and clinical insights for hospital and health systems.

Nomad Health is a workforce marketplace that facilitates the hiring of physicians and nurses on behalf of healthcare provider organizations.

SQZ Biotech is the pioneering company whose CellSqueeze cell therapy platform enables a variety of materials to enter a cell with unprecedented efficacy.

Suono Bio, Inc. enables ultrasonic targeted delivery of therapeutics and macromolecules across tissues without the need for reformulation or encapsulation. Preclinical studies have demonstrated the capacity to deliver small molecules, proteins, vaccines, and nucleic acids locally to specific tissues such as the gastrointestinal tract, as well as systemically in a formulation-independent manner.

Quentis is at the forefront of the next generation of immuno-oncology drug development to help all cancer patients benefit from immunotherapy.

Kronos Bio is dedicated to the discovery and development of novel small molecule modulators of historically undruggable oncology targets.

Montis Biosciences is targeting perivascular macrophages to restore tumor micro environment vasculature- increase immune infiltration and alleviate the immune suppressive TME.

Amunix is a platform company developing technology for tumor-specific activation of T-cell engagers.

Thirty Madison is an end-to-end digital health platform that connects patients directly to provider specialists.

ByHeart is a fully integrated infant nutrition company dedicated to translating leading nutrition science and breastmilk research into products that set the best foundation for babies’ health.

QurAlis is developing precision therapies for the treatment of ALS.

Vico Therapeutics is developing therapies for rare neurological diseases, leveraging RNA modifying technologies.

Volastra is a preclinical oncology company targeting chromosomal instability in metastatic cancers.

Sesh Therapy offers online support group sessions facilitated by a trained therapist.

Ankyra is developing a platform to significantly improve both the safety and efficacy of cytokine immunotherapies for cancer.

IconOvir engages in research and development in cancer viral gene therapy.

The One Health Company, maker of FidoCure®, is bringing the latest advances in human oncology – individualized, precision medicine – to dogs with cancer.